Clinical Trials Browser

Phase 1/2 × Lymphoma, T-Cell, Peripheral × Folic Acid × Clear all

NCT02013362 2017-11-09

Phase I/II Clinical Study of Pralatrexate in Japanese Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Phase 1/2 Completed

Lymphoma, T-Cell, Peripheral